Q99683 (M3K5_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 143.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Mitogen-activated protein kinase kinase kinase 5 EC=2.7.11.25 Alternative name(s): Apoptosis signal-regulating kinase 1 Short name=ASK-1 MAPK/ERK kinase kinase 5 Short name=MEK kinase 5 Short name=MEKK 5 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 1374 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. Plays an important role in the cascades of cellular responses evoked by changes in the environment. Mediates signaling for determination of cell fate such as differentiation and survival. Plays a crucial role in the apoptosis signal transduction pathway through mitochondria-dependent caspase activation. MAP3K5/ASK1 is required for the innate immune response, which is essential for host defense against a wide range of pathogens. Mediates signal transduction of various stressors like oxidative stress as well as by receptor-mediated inflammatory signals, such as the tumor necrosis factor (TNF) or lipopolysaccharide (LPS). Once activated, acts as an upstream activator of the MKK/JNK signal transduction cascade and the p38 MAPK signal transduction cascade through the phosphorylation and activation of several MAP kinase kinases like MAP2K4/SEK1, MAP2K3/MKK3, MAP2K6/MKK6 and MAP2K7/MKK7. These MAP2Ks in turn activate p38 MAPKs and c-jun N-terminal kinases (JNKs). Both p38 MAPK and JNKs control the transcription factors activator protein-1 (AP-1). Ref.1 Ref.2 Ref.5 Ref.6 Ref.8 Ref.9 Ref.10 Ref.12 Ref.13 Ref.14 Ref.17 Ref.18 Ref.20 Ref.22 Ref.23 Ref.28 Ref.32 |
| Catalytic activity | ATP + a protein = ADP + a phosphoprotein. |
| Cofactor | Magnesium. |
| Enzyme regulation | Activated by various stressors, including oxidative stress, endoplasmic reticulum stress, and calcium overload, as well as by receptor-mediated inflammatory signals, such as the tumor necrosis factor (TNF) and lipopolysaccharide (LPS). Homophilic association of MAP3K5/ASK1 through the C-terminal coiled-coil domains and the heteromeric complex formation of MAP3K5/ASK1 with the reduced form of thioredoxin (TXN), constitutes an inactive form of the kinase. Upon ROS-induced dissociation of TXN from MAP3K5/ASK1, TRAF2 and TRAF6 are reciprocally recruited to MAP3K5/ASK1 and form the active MAP3K5/ASK1 signalosome, in which TRAF2 and TRAF6 appear to facilitate the active configuration of MAP3K5/ASK1. MAP3K5/ASK1 activity is also regulated through several phosphorylation and dephosphorylation events. Thr-838 is an activating phosphorylation site that is autophosphorylated and phosphorylated by MAP3K6/ASK2 and dephosphorylated by PPP5C. Ser-83 and Ser-1033 are inactivating phosphorylation sites, the former of which is phosphorylated by AKT1 and AKT2. Phosphorylation of Ser-966 induces association of MAP3K5/ASK1 with the 14-3-3 family proteins, which suppresses MAP3K5/ASK1 activity. Calcium/calmodulin-activated protein phosphatase calcineurin (PPP3CA) has been shown to directly dephosphorylate this site. SOCS1 binds to ASK1 by recognizing phosphorylation of Tyr-718 and induces MAP3K5/ASK1 degradation in endothelial cells. Also dephosphorylated and activated by PGAM5. Contains an N-terminal autoinhibitory domain. Ref.5 Ref.6 Ref.8 Ref.10 Ref.12 Ref.14 Ref.17 Ref.18 Ref.19 Ref.20 Ref.23 Ref.25 Ref.29 Ref.31 |
| Subunit structure | Homodimer when inactive. Binds both upstream activators and downstream substrates in multimolecular complexes. Associates with and inhibited by HIV-1 Nef. Part of a cytoplasmic complex made of HIPK1, DAB2IP and MAP3K5 in response to TNF. This complex formation promotes MAP3K5-JNK activation and subsequent apoptosis. Interacts with SOCS1 which recognizes phosphorylation of Tyr-718 and induces MAP3K5/ASK1 degradation in endothelial cells. Interacts with the 14-3-3 family proteins such as YWHAB, YWHAE, YWHAQ, YWHAH, YWHAZ and SFN. Interacts with ARRB2, BIRC2, DAB2IP, IGF1R, MAP3K6/ASK2, PGAM5, PIM1, PPP5C, SOCS1, STUB1, TRAF2, TRAF6 and TXN. Interacts with ERN1 in a TRAF2-dependent manner. Interacts with calcineurin subunit PPP3R1 and with PPM1L By similarity. Interacts (via N-terminus) with RAF1 and this interaction inhibits the proapoptotic function of MAP3K5. Ref.5 Ref.6 Ref.7 Ref.8 Ref.10 Ref.11 Ref.12 Ref.15 Ref.16 Ref.17 Ref.18 Ref.19 Ref.21 Ref.22 Ref.24 Ref.25 Ref.26 Ref.27 Ref.28 Ref.29 Ref.30 Ref.31 Ref.32 Ref.33 Ref.34 Ref.39 Ref.40 |
| Subcellular location | Cytoplasm. Endoplasmic reticulum. Note: Interaction with 14-3-3 proteins alters the distribution of MAP3K5/ASK1 and restricts it to the perinuclear endoplasmic reticulum region. Ref.12 Ref.19 Ref.22 Ref.27 |
| Tissue specificity | Abundantly expressed in heart and pancreas. |
| Induction | By TNF. Inhibited by HIV-1 Nef. Ref.5 Ref.6 Ref.8 Ref.10 Ref.12 Ref.14 Ref.17 Ref.18 Ref.19 Ref.20 Ref.23 Ref.25 Ref.29 Ref.31 |
| Post-translational modification | Phosphorylated at Thr-838 through autophosphorylation and by MAP3K6/ASK2 which leads to activation. Thr-838 is dephosphorylated by PPP5C. Ser-83 and Ser-1033 are inactivating phosphorylation sites, the former of which is phosphorylated by AKT1 and AKT2. Phosphorylated at Ser-966 which induces association of MAP3K5/ASK1 with the 14-3-3 family proteins and suppresses MAP3K5/ASK1 activity. Calcineurin (CN) dephosphorylates this site. Also dephosphorylated and activated by PGAM5. Ref.12 Ref.14 Ref.18 Ref.19 Ref.20 Ref.23 Ref.25 Ref.29 Ref.31 Ref.35 Ref.39 Ref.40 Ref.43 Ubiquitinated. Tumor necrosis factor (TNF) induces TNFR2-dependent ubiquitination leading to proteasomal degradation. Ref.26 Ref.32 |
| Sequence similarities | Belongs to the protein kinase superfamily. STE Ser/Thr protein kinase family. MAP kinase kinase kinase subfamily. Contains 1 protein kinase domain. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| itself | 3 | EBI-476263,EBI-476263 | ||
| AKT1 | P31749 | 2 | EBI-476263,EBI-296087 | |
| DAXX | Q9UER7 | 6 | EBI-476263,EBI-77321 | |
| MAP2K3 | P46734 | 2 | EBI-476263,EBI-602462 | |
| Map3k6 | Q9WTR2 | 3 | EBI-476263,EBI-1254790 | From a different organism. |
| TXN | P10599 | 2 | EBI-476263,EBI-594644 | |
| YWHAB | P31946 | 3 | EBI-476263,EBI-359815 | |
| YWHAZ | P63104 | 2 | EBI-476263,EBI-347088 | |
| ZNF622 | Q969S3 | 14 | EBI-476263,EBI-2687480 |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 1374 | 1374 | Mitogen-activated protein kinase kinase kinase 5 | PRO_0000086249 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Domain | 680 – 938 | 259 | Protein kinase | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Nucleotide binding | 686 – 694 | 9 | ATP By similarity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Coiled coil | 1245 – 1285 | 41 | Potential | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sites | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Active site | 803 | 1 | Proton acceptor By similarity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Binding site | 709 | 1 | ATP | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 83 | 1 | Phosphoserine; by PIM1, PKB/AKT1 and PKB/AKT2 Ref.14 Ref.20 Ref.39 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 718 | 1 | Phosphotyrosine Ref.29 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 813 | 1 | Phosphothreonine; by autocatalysis Ref.43 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 838 | 1 | Phosphothreonine; by autocatalysis, MELK and MAP3K6 Ref.12 Ref.18 Ref.31 Ref.35 Ref.40 Ref.43 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 842 | 1 | Phosphothreonine; by autocatalysis Ref.43 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 958 | 1 | Phosphoserine | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 966 | 1 | Phosphoserine Ref.23 Ref.25 Ref.40 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 976 | 1 | Phosphothreonine By similarity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 1029 | 1 | Phosphoserine Ref.36 Ref.37 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 1033 | 1 | Phosphoserine Ref.25 Ref.36 Ref.37 Ref.38 Ref.40 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 1006 | 1 | G → R. Ref.44 Corresponds to variant rs45626535 [ dbSNP | Ensembl ]. | VAR_040693 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 1214 | 1 | I → T. Ref.44 Corresponds to variant rs56379668 [ dbSNP | Ensembl ]. | VAR_040694 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 1250 | 1 | I → V. Ref.44 Corresponds to variant rs35551087 [ dbSNP | Ensembl ]. | VAR_040695 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 1314 | 1 | T → I. Ref.44 Corresponds to variant rs45599539 [ dbSNP | Ensembl ]. | VAR_040696 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 1315 | 1 | D → N. Ref.44 Corresponds to variant rs41288957 [ dbSNP | Ensembl ]. | VAR_040697 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 709 | 1 | K → M: Loss of kinase activity. Inhibits activation of JNK and apoptosis mediated by TNFRSF6 and DAXX. Ref.7 Ref.31 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 709 | 1 | K → R: Loss of kinase activity. Abolishes DAXX-mediated apoptosis. Ref.7 Ref.31 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 966 | 1 | S → A: Enhanced induction of apoptosis, increased kinase activity, and loss of YWHAG binding. Ref.8 Ref.25 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 1033 | 1 | S → A: Enhanced induction of apoptosis and increased kinase activity. Ref.25 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 673 – 675 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 681 – 683 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 685 – 688 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 690 – 699 | 10 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 700 – 702 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 705 – 712 | 8 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 720 – 730 | 11 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 740 – 746 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 749 – 755 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 758 – 761 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 762 – 768 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 777 – 796 | 20 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 806 – 808 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 809 – 812 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 813 – 815 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 818 – 820 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 823 – 825 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 827 – 829 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 843 – 845 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 848 – 853 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 854 – 857 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 860 – 876 | 17 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 882 – 884 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 887 – 897 | 11 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 909 – 917 | 9 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 923 – 925 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 929 – 933 | 5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 936 – 938 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Molecular cloning and characterization of a novel protein kinase with a catalytic domain homologous to mitogen-activated protein kinase kinase kinase." Wang X.S., Diener K., Jannuzzi D., Trollinger D., Tan T.-H., Lichenstein H., Zukowski M., Yao Z. J. Biol. Chem. 271:31607-31611(1996) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], FUNCTION. |
| [2] | "Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways." Ichijo H., Nishida E., Irie K., ten Dijke P., Saitoh M., Moriguchi T., Takagi M., Matsumoto K., Miyazono K., Gotoh Y. Science 275:90-94(1997) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], FUNCTION. |
| [3] | "The DNA sequence and analysis of human chromosome 6." Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L., Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D., Andrews T.D. Beck S.Nature 425:805-811(2003) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [4] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Eye and Lung. |
| [5] | "Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1." Saitoh M., Nishitoh H., Fujii M., Takeda K., Tobiume K., Sawada Y., Kawabata M., Miyazono K., Ichijo H. EMBO J. 17:2596-2606(1998) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH TXN, ENZYME REGULATION, FUNCTION. |
| [6] | "ASK1 is essential for JNK/SAPK activation by TRAF2." Nishitoh H., Saitoh M., Mochida Y., Takeda K., Nakano H., Rothe M., Miyazono K., Ichijo H. Mol. Cell 2:389-395(1998) [PubMed] [Europe PMC] [Abstract] Cited for: ENZYME REGULATION, INTERACTION WITH TRAF2, FUNCTION. |
| [7] | "Activation of apoptosis signal-regulating kinase 1 (ASK1) by the adapter protein Daxx." Chang H.Y., Nishitoh H., Yang X., Ichijo H., Baltimore D. Science 281:1860-1863(1998) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH DAXX, MUTAGENESIS OF LYS-709. |
| [8] | "Suppression of apoptosis signal-regulating kinase 1-induced cell death by 14-3-3 proteins." Zhang L., Chen J., Fu H. Proc. Natl. Acad. Sci. U.S.A. 96:8511-8515(1999) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH 14-3-3 PROTEINS, ENZYME REGULATION, MUTAGENESIS OF SER-966, FUNCTION. |
| [9] | "Execution of apoptosis signal-regulating kinase 1 (ASK1)-induced apoptosis by the mitochondria-dependent caspase activation." Hatai T., Matsuzawa A., Inoshita S., Mochida Y., Kuroda T., Sakamaki K., Kuida K., Yonehara S., Ichijo H., Takeda K. J. Biol. Chem. 275:26576-26581(2000) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION IN APOPTOSIS. |
| [10] | "Activation of apoptosis signal-regulating kinase 1 (ASK1) by tumor necrosis factor receptor-associated factor 2 requires prior dissociation of the ASK1 inhibitor thioredoxin." Liu H., Nishitoh H., Ichijo H., Kyriakis J.M. Mol. Cell. Biol. 20:2198-2208(2000) [PubMed] [Europe PMC] [Abstract] Cited for: SUBUNIT, INTERACTION WITH TRAF2, ENZYME REGULATION, FUNCTION. |
| [11] | "Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3." McDonald P.H., Chow C.W., Miller W.E., Laporte S.A., Field M.E., Lin F.-T., Davis R.J., Lefkowitz R.J. Science 290:1574-1577(2000) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH ARRB2. |
| [12] | "Negative feedback regulation of ASK1 by protein phosphatase 5 (PP5) in response to oxidative stress." Morita K., Saitoh M., Tobiume K., Matsuura H., Enomoto S., Nishitoh H., Ichijo H. EMBO J. 20:6028-6036(2001) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH PPP5C, DEPHOSPHORYLATION AT THR-838, SUBCELLULAR LOCATION, ENZYME REGULATION, FUNCTION. |
| [13] | "Apoptosis signal-regulating kinase 1 (ASK1) is an intracellular inducer of keratinocyte differentiation." Sayama K., Hanakawa Y., Shirakata Y., Yamasaki K., Sawada Y., Sun L., Yamanishi K., Ichijo H., Hashimoto K. J. Biol. Chem. 276:999-1004(2001) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION IN KERATINOCYTE DIFFERENTIATION. |
| [14] | "Akt phosphorylates and negatively regulates apoptosis signal-regulating kinase 1." Kim A.H., Khursigara G., Sun X., Franke T.F., Chao M.V. Mol. Cell. Biol. 21:893-901(2001) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION AT SER-83, ENZYME REGULATION, FUNCTION. |
| [15] | "HIV-1 Nef inhibits ASK1-dependent death signalling providing a potential mechanism for protecting the infected host cell." Geleziunas R., Xu W., Takeda K., Ichijo H., Greene W.C. Nature 410:834-838(2001) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH HIV-1 NEF, INHIBITION BY HIV-1 NEF. |
| [16] | "Raf-1 promotes cell survival by antagonizing apoptosis signal-regulating kinase 1 through a MEK-ERK independent mechanism." Chen J., Fujii K., Zhang L., Roberts T., Fu H. Proc. Natl. Acad. Sci. U.S.A. 98:7783-7788(2001) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH RAF1. |
| [17] | "Involvement of ASK1 in Ca2+-induced p38 MAP kinase activation." Takeda K., Matsuzawa A., Nishitoh H., Tobiume K., Kishida S., Ninomiya-Tsuji J., Matsumoto K., Ichijo H. EMBO Rep. 5:161-166(2004) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH TRAF2 AND ERN1, ENZYME REGULATION, FUNCTION IN ER STRESS RESPONSE. |
| [18] | "Activation of apoptosis signal-regulating kinase 1 by the stress-induced activating phosphorylation of pre-formed oligomer." Tobiume K., Saitoh M., Ichijo H. J. Cell. Physiol. 191:95-104(2002) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, HOMODIMERIZATION, ENZYME REGULATION, PHOSPHORYLATION AT THR-838. |
| [19] | "Type 1 insulin-like growth factor receptor (IGF-IR) signaling inhibits apoptosis signal-regulating kinase 1 (ASK1)." Galvan V., Logvinova A., Sperandio S., Ichijo H., Bredesen D.E. J. Biol. Chem. 278:13325-13332(2003) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH IGF1R, PHOSPHORYLATION, ENZYME REGULATION, SUBCELLULAR LOCATION. |
| [20] | "AKT2 inhibition of cisplatin-induced JNK/p38 and Bax activation by phosphorylation of ASK1: implication of AKT2 in chemoresistance." Yuan Z.Q., Feldman R.I., Sussman G.E., Coppola D., Nicosia S.V., Cheng J.Q. J. Biol. Chem. 278:23432-23440(2003) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION AT SER-83, ENZYME REGULATION, FUNCTION. |
| [21] | "AIP1 mediates TNF-alpha-induced ASK1 activation by facilitating dissociation of ASK1 from its inhibitor 14-3-3." Zhang R., He X., Liu W., Lu M., Hsieh J.-T., Min W. J. Clin. Invest. 111:1933-1943(2003) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH DAB2IP. |
| [22] | "Interaction of apoptosis signal-regulating kinase 1 with isoforms of 14-3-3 proteins." Subramanian R.R., Zhang H., Wang H., Ichijo H., Miyashita T., Fu H. Exp. Cell Res. 294:581-591(2004) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH YWHAB; YWHAE; YWHAH; YWHAQ; YWHAZ AND SFN, FUNCTION, SUBCELLULAR LOCATION. |
| [23] | "Activation of apoptosis signal-regulating kinase 1 by reactive oxygen species through dephosphorylation at serine 967 and 14-3-3 dissociation." Goldman E.H., Chen L., Fu H. J. Biol. Chem. 279:10442-10449(2004) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION AT SER-966, ENZYME REGULATION, FUNCTION. |
| [24] | "AIP1/DAB2IP, a novel member of the Ras-GAP family, transduces TRAF2-induced ASK1-JNK activation." Zhang H., Zhang R., Luo Y., D'Alessio A., Pober J.S., Min W. J. Biol. Chem. 279:44955-44965(2004) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH DAB2IP. |
| [25] | "Negative control of apoptosis signal-regulating kinase 1 through phosphorylation of Ser-1034." Fujii K., Goldman E.H., Park H.R., Zhang L., Chen J., Fu H. Oncogene 23:5099-5104(2004) [PubMed] [Europe PMC] [Abstract] Cited for: ENZYME REGULATION, PHOSPHORYLATION AT SER-966 AND SER-1033, MUTAGENESIS OF SER-966 AND SER-1033, INTERACTION WITH YWHAG. |
| [26] | "C-terminus of heat shock protein 70-interacting protein facilitates degradation of apoptosis signal-regulating kinase 1 and inhibits apoptosis signal-regulating kinase 1-dependent apoptosis." Hwang J.R., Zhang C., Patterson C. Cell Stress Chaperones 10:147-156(2005) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH STUB1, UBIQUITINATION. |
| [27] | "Tumor necrosis factor alpha-induced desumoylation and cytoplasmic translocation of homeodomain-interacting protein kinase 1 are critical for apoptosis signal-regulating kinase 1-JNK/p38 activation." Li X., Zhang R., Luo D., Park S.-J., Wang Q., Kim Y., Min W. J. Biol. Chem. 280:15061-15070(2005) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH HIPK1, SUBCELLULAR LOCATION. |
| [28] | "Recruitment of tumor necrosis factor receptor-associated factor family proteins to apoptosis signal-regulating kinase 1 signalosome is essential for oxidative stress-induced cell death." Noguchi T., Takeda K., Matsuzawa A., Saegusa K., Nakano H., Gohda J., Inoue J., Ichijo H. J. Biol. Chem. 280:37033-37040(2005) [PubMed] [Europe PMC] [Abstract] Cited for: SUBUNIT, INTERACTION WITH TRAF2, FUNCTION. |
| [29] | "SOCS1 inhibits tumor necrosis factor-induced activation of ASK1-JNK inflammatory signaling by mediating ASK1 degradation." He Y., Zhang W., Zhang R., Zhang H., Min W. J. Biol. Chem. 281:5559-5566(2006) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION AT TYR-718, INTERACTION WITH SOCS1, ENZYME REGULATION. |
| [30] | "Regulation of apoptosis signal-regulating kinase 1 by protein phosphatase 2Cepsilon." Saito J., Toriumi S., Awano K., Ichijo H., Sasaki K., Kobayashi T., Tamura S. Biochem. J. 405:591-596(2007) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH PPM1L. |
| [31] | "Apoptosis signal-regulating kinase (ASK) 2 functions as a mitogen-activated protein kinase kinase kinase in a heteromeric complex with ASK1." Takeda K., Shimozono R., Noguchi T., Umeda T., Morimoto Y., Naguro I., Tobiume K., Saitoh M., Matsuzawa A., Ichijo H. J. Biol. Chem. 282:7522-7531(2007) [PubMed] [Europe PMC] [Abstract] Cited for: ENZYME REGULATION, INTERACTION WITH MAP3K5, PHOSPHORYLATION AT THR-838, MUTAGENESIS OF LYS-709. |
| [32] | "Tumor necrosis factor receptor 2 signaling induces selective c-IAP1-dependent ASK1 ubiquitination and terminates mitogen-activated protein kinase signaling." Zhao Y., Conze D.B., Hanover J.A., Ashwell J.D. J. Biol. Chem. 282:7777-7782(2007) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH BIRC2, UBIQUITINATION, FUNCTION. |
| [33] | "Thioredoxin and TRAF family proteins regulate reactive oxygen species-dependent activation of ASK1 through reciprocal modulation of the N-terminal homophilic interaction of ASK1." Fujino G., Noguchi T., Matsuzawa A., Yamauchi S., Saitoh M., Takeda K., Ichijo H. Mol. Cell. Biol. 27:8152-8163(2007) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH TRAF2; TRAF6 AND TXN. |
| [34] | "The beta-arrestin-2 scaffold protein promotes c-Jun N-terminal kinase-3 activation by binding to its nonconserved N terminus." Guo C., Whitmarsh A.J. J. Biol. Chem. 283:15903-15911(2008) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH ARRB2. |
| [35] | "Murine protein serine/threonine kinase 38 activates apoptosis signal-regulating kinase 1 via Thr 838 phosphorylation." Jung H., Seong H.A., Ha H. J. Biol. Chem. 283:34541-34553(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION AT THR-838. |
| [36] | "Phosphoproteome of resting human platelets." Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J., Schuetz C., Walter U., Gambaryan S., Sickmann A. J. Proteome Res. 7:526-534(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1029 AND SER-1033, MASS SPECTROMETRY. Tissue: Platelet. |
| [37] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1029 AND SER-1033, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [38] | "Large-scale proteomics analysis of the human kinome." Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G., Mann M., Daub H. Mol. Cell. Proteomics 8:1751-1764(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1033, MASS SPECTROMETRY. |
| [39] | "PIM1 phosphorylates and negatively regulates ASK1-mediated apoptosis." Gu J.J., Wang Z., Reeves R., Magnuson N.S. Oncogene 28:4261-4271(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION AT SER-83 BY PIM1, INTERACTION WITH PIM1. |
| [40] | "Mitochondrial phosphoglycerate mutase 5 uses alternate catalytic activity as a protein serine/threonine phosphatase to activate ASK1." Takeda K., Komuro Y., Hayakawa T., Oguchi H., Ishida Y., Murakami S., Noguchi T., Kinoshita H., Sekine Y., Iemura S., Natsume T., Ichijo H. Proc. Natl. Acad. Sci. U.S.A. 106:12301-12305(2009) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH PGAM5, PHOSPHORYLATION AT THR-838; SER-966 AND SER-1033. |
| [41] | "Apoptosis signal-regulating kinase 1 in stress and immune response." Takeda K., Noguchi T., Naguro I., Ichijo H. Annu. Rev. Pharmacol. Toxicol. 48:199-225(2008) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW ON ENZYME REGULATION, REVIEW ON FUNCTION. |
| [42] | "The roles of ASK family proteins in stress responses and diseases." Hattori K., Naguro I., Runchel C., Ichijo H. Cell Commun. Signal. 7:9-9(2009) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW ON ENZYME REGULATION, REVIEW ON FUNCTION. |
| [43] | "Structural and functional characterization of the human protein kinase ASK1." Bunkoczi G., Salah E., Filippakopoulos P., Fedorov O., Muller S., Sobott F., Parker S.A., Zhang H., Min W., Turk B.E., Knapp S. Structure 15:1215-1226(2007) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 659-951, PHOSPHORYLATION AT THR-813; THR-838 AND THR-842. |
| [44] | "Patterns of somatic mutation in human cancer genomes." Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G. Stratton M.R.Nature 446:153-158(2007) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS [LARGE SCALE ANALYSIS] ARG-1006; THR-1214; VAL-1250; ILE-1314 AND ASN-1315. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | U67156 mRNA. Translation: AAC50894.1. D84476 mRNA. Translation: BAA12684.2. AL024508, AL121933 Genomic DNA. Translation: CAI20176.1. AL121933, AL024508 Genomic DNA. Translation: CAI15470.1. BC054503 mRNA. Translation: AAH54503.1. BC088829 mRNA. Translation: AAH88829.1. | ||||||||||||||||||
| IPI | IPI00412433. | ||||||||||||||||||
| RefSeq | NP_005914.1. NM_005923.3. | ||||||||||||||||||
| UniGene | Hs.186486. | ||||||||||||||||||
3D structure databases | |||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||
| ProteinModelPortal | Q99683. | ||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||
| DIP | DIP-29516N. | ||||||||||||||||||
| IntAct | Q99683. 29 interactions. | ||||||||||||||||||
| MINT | MINT-99796. | ||||||||||||||||||
| STRING | 9606.ENSP00000351908. | ||||||||||||||||||
PTM databases | |||||||||||||||||||
| PhosphoSite | Q99683. | ||||||||||||||||||
Polymorphism databases | |||||||||||||||||||
| DMDM | 6685617. | ||||||||||||||||||
Proteomic databases | |||||||||||||||||||
| PaxDb | Q99683. | ||||||||||||||||||
| PRIDE | Q99683. | ||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||
| DNASU | 4217. | ||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||
Genome annotation databases | |||||||||||||||||||
| Ensembl | ENST00000359015; ENSP00000351908; ENSG00000197442. | ||||||||||||||||||
| GeneID | 4217. | ||||||||||||||||||
| KEGG | hsa:4217. | ||||||||||||||||||
| UCSC | uc003qhc.3. human. | ||||||||||||||||||
Organism-specific databases | |||||||||||||||||||
| CTD | 4217. | ||||||||||||||||||
| GeneCards | GC06M136919. | ||||||||||||||||||
| HGNC | HGNC:6857. MAP3K5. | ||||||||||||||||||
| HPA | CAB007824. | ||||||||||||||||||
| MIM | 602448. gene. | ||||||||||||||||||
| neXtProt | NX_Q99683. | ||||||||||||||||||
| PharmGKB | PA30601. | ||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||
| eggNOG | COG0515. | ||||||||||||||||||
| HOVERGEN | HBG006305. | ||||||||||||||||||
| InParanoid | Q99683. | ||||||||||||||||||
| KO | K04426. | ||||||||||||||||||
| OMA | HEWNFSA. | ||||||||||||||||||
| OrthoDB | EOG4XSKP2. | ||||||||||||||||||
| PhylomeDB | Q99683. | ||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||
| BRENDA | 2.7.12.2. 2681. | ||||||||||||||||||
| Pathway_Interaction_DB | pi3kciaktpathway. Class I PI3K signaling events mediated by Akt. hivnefpathway. HIV-1 Nef: Negative effector of Fas and TNF-alpha. mtor_4pathway. mTOR signaling pathway. p38_mkk3_6pathway. p38 MAPK signaling pathway. met_pathway. Signaling events activated by Hepatocyte Growth Factor Receptor (c-Met). tnfpathway. TNF receptor signaling pathway. | ||||||||||||||||||
Gene expression databases | |||||||||||||||||||
| ArrayExpress | Q99683. | ||||||||||||||||||
| Bgee | Q99683. | ||||||||||||||||||
| CleanEx | HS_MAP3K5. | ||||||||||||||||||
| Genevestigator | Q99683. | ||||||||||||||||||
| GermOnline | ENSG00000197442. Homo sapiens. | ||||||||||||||||||
Family and domain databases | |||||||||||||||||||
| InterPro | IPR025136. DUF4071. IPR011009. Kinase-like_dom. IPR000719. Prot_kinase_cat_dom. IPR017441. Protein_kinase_ATP_BS. IPR013761. SAM/pointed. IPR002290. Ser/Thr_dual-sp_kinase_dom. IPR008271. Ser/Thr_kinase_AS. [Graphical view] | ||||||||||||||||||
| Pfam | PF13281. DUF4071. 1 hit. PF00069. Pkinase. 1 hit. [Graphical view] | ||||||||||||||||||
| SMART | SM00220. S_TKc. 1 hit. [Graphical view] | ||||||||||||||||||
| SUPFAM | SSF56112. Kinase_like. 1 hit. SSF47769. SAM_homology. 1 hit. | ||||||||||||||||||
| PROSITE | PS00107. PROTEIN_KINASE_ATP. 1 hit. PS50011. PROTEIN_KINASE_DOM. 1 hit. PS00108. PROTEIN_KINASE_ST. 1 hit. [Graphical view] | ||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||
Other | |||||||||||||||||||
| BindingDB | Q99683. | ||||||||||||||||||
| ChEMBL | CHEMBL5285. | ||||||||||||||||||
| ChiTaRS | MAP3K5. human. | ||||||||||||||||||
| EvolutionaryTrace | Q99683. | ||||||||||||||||||
| GenomeRNAi | 4217. | ||||||||||||||||||
| NextBio | 16633. | ||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||
Entry information
| Entry name | M3K5_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q99683 Secondary accession number(s): Q5THN3, Q99461 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human and mouse protein kinases Human and mouse protein kinases: classification and index |
| Human chromosome 6 Human chromosome 6: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
